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Abstract Inflammasomes are cytosolic multiprotein com-
plexes that can proteolytically activate caspase-1. Activated
caspase-1 is needed for the maturation and secretion of
interleukin (IL)-1β and IL-18. In the past decade, there has
been tremendous progress in our knowledge of inflamma-
some function and IL-1 signaling, mainly in cells of the
innate immune system, such as monocytes, macrophages,
neutrophils, and dendritic cells. Because nonimmune cells,
including keratinocytes, synovial cells, or astrocytes, can
form an interface between the body and the environment or
a defined compartment (brain, joint), they are important
guardians for the detection of danger signals and the
consecutive initiation of an inflammatory response. They
are present in anatomical compartments that are less
accessible to myeloid cells and thus can fulfill tasks usually
performed by residential macrophages. This review focuses
on recent progress in our understanding of the processing
and functional role of IL-1 in epithelial, mesenchymal, and
neuronal cells and in conditions such as tissue repair.
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Introduction
It has been 25 years since the cloning of Interleukin (IL)-1β
and IL-1α [1, 2]. Originally, these cytokines were described
as fever-inducing agents, and it is now clear that they are
among the most potent proinflammatory cytokines
expressed in mammals [3, 4]. While IL-1β and IL-1α
share similar physiological properties, their processing is
distinct. Pathways leading to IL-1α cleavage are yet to be
characterized in detail, and the functional consequences of
cleavage remain unclear as, unlike IL-1β, IL-1α does not
have to be cleaved to exhibit biological activity. Initial
studies described the Ca2+-dependent protease calpain as
one protease able to process IL-1α [5], although this has yet
to be demonstrated genetically.
On the other hand, the mechanism of cleavage of pro-IL-
1β is well characterized. Eight years after the cloning of IL-
1β, caspase-1 was identified as the essential protease that
processes inactive pro-IL-1β to biologically active mature
IL-1β [6]. Subsequently, the molecular pathways leading to
caspase-1 activation were discovered. Large caspase-1
activating protein complexes termed the inflammasomes
are formed in response to numerous biologically and
chemically unrelated stimuli [7]. An inflammasome con-
sists of three major components: (1) a receptor such as a
nucleotide oligomerisation domain (NOD)-like receptor
(NLR), which acts as an intracellular sensor and induces
complex formation; (2) in most cases, the adaptor protein
ASC (apoptosis speck-like protein containing a caspase
recruitment domain (CARD)), which recruits pro-caspase-1
to the complex through homotypic CARD interactions; and,
(3) pro-caspase-1 [7–9]. The close proximity of pro-
caspase-1 in this complex results in autocatalytic cleavage
of caspase-1 and therefore its activation. To date, the NLR
family consists of 22 human receptors that have been
classified according to a common domain structure. While
the function of most NLRPs remains elusive, NLRP1,
NLRP3, and the NLRP-related protein, NLRC4 (IPAF),
have been extensively characterized and are known to form
inflammasomes that activate pro-caspase-1 [7, 10]. How-
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ever, these inflammasomes have primarily been studied in
myeloid lineages, and their function in nonmyeloid cells
and their role in noninflammatory processes are only
beginning to emerge.
Skin
As skin is one of the body's largest primary barriers to the
environment, one of its main functions is to protect the
body against danger, such as chemical, physical, or
microbial insults. The skin consists of two major compart-
ments, the epidermis and the underlying dermis. Keratino-
cytes are the major cell type of the epidermis and they
constantly renew from the basal layer to the differentiated
corneal layer, which forms the main mechanical barrier that
repels foreign agents and prevents dehydration. While
innate immune cells such as macrophages and dermal
dendritic cells are present in the dermis, Langerhans cells
and epidermal dendritic cells are the only innate immune
cells in the epidermal layer (Fig. 1a). Besides a small
number of T cells (approximately 2% of the total skin),
melanin pigment-producing melanocytes are the fourth
major cell type in the epidermis [11].
To be able to sense pathogens and to elicit an immune
response prior to infiltrating myeloid cells, keratinocytes
can detect microbial or nonmicrobial danger signals
through the recognition of conserved molecular patterns
termed pathogen- or danger-associated molecular patterns
(PAMPs or DAMPs) (Fig. 1b). If presented to the outer
membranes of the cell, these patterns can be sensed by Toll-
like receptors, which are present either on the cell surface
(TLR1, 2, 4, 5, 6) or on the endosomal membranes (TLR3,
TLR9), to initiate immune responses [12, 13]. NLRs are a
recently identified group of proteins that are the cytosolic
counterparts of TLRs. As mentioned above, some of the
NLRs have the capacity to form multiprotein complexes
termed inflammasomes, which leads to caspase-1 activation
and the generation of mature biologically active IL-1β. To
date, the expression and function of the NLRP1 and the
NLRP3 inflammasome, and of inflammatory caspases, have
been demonstrated both in rodent and human skin [14]. The
NLRP3 inflammasome, the most well-characterized inflam-
masome in myeloid cells, is known to be activated by
ultraviolet B light, to induce sunburn-associated skin
inflammation [15], and also in contact hypersensitivity
reactions [14, 16], cutaneous T cell-mediated reactions
directed against defined antigens. Watanabe et al. provided
in vivo evidence for the dependency of contact hypersensi-
tivity reactions on the presence of the IL-1 receptor (IL-1R)
and the inflammasome components NLRP3 and ASC, while
Sutterwala et al. further narrowed down the role of the
inflammasome to the sensitization phase.
Caspase-1 and the inflammasome may not be only
involved in cutaneous reactions directed against exogenous
danger signals. Increased caspase-1 activity was detected in
the lesional skin of psoriasis [17], which is a chronic,
noninfectious inflammatory skin disease, characterized by
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Fig. 1 Nonimmune cells are a source of proinflammatory cytokines,
such as IL-1β. Nonimmune cells, including keratinocytes, synovial
cells, or astrocytes, can form an interface between the body and the
environment or a defined compartment (brain, joint) that is not readily
accessible to myeloid cells. Therefore, they are important guardians
for the detection of danger signals and the consecutive initiation of an
inflammatory response. By doing so, they are able to recruit myeloid
cells, such as neutrophils and macrophages, to the site of insult
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silvery-white scaly patches or plaques. A second important
autoinflammatory skin disease is vitiligo, which causes
depigmented white patches due to the loss of melanocytes.
In genetic association analyses, variants of NLRP1 were
identified as a candidate gene for generalized vitiligo [18]
or vitiligo-associated autoimmune diseases [19]. While
these genetic association studies did not address the actual
presence of NLRP1 in lesional skin, the protein expression
of NLRP1 in rat skin was recently confirmed [20].
Human skin is known to possess caspase-1, caspase-5,
ASC, pro-IL-1α, pro-IL-1β, pIL-18 [15], NLRP1, and
NLRP3 [14]. For murine skin, the expression pattern is
controversial. On the one hand, Watanabe et al. exposed
murine keratinocytes to the skin irritant 2,4,6-trinitro-
chlorobenzene (TNCB), leading to the secretion of mature
IL-1β secretion, while others argue that pIL-1β is absent in
murine keratinocytes [15, 21].
Connective Tissue and Tissue Repair
The connective tissue supports and links other tissues of
our body. Therefore, an intact connective tissue is necessary
for the maintenance and remodeling of our body. Unlike
other tissues, it has cells, namely, fibroblasts, scattered
throughout the tissue, which maintain its integrity by
producing extracellular matrix (ECM). Similar to the skin,
an increasing amount of evidence suggests that fibroblasts,
endothelial cells, and myoblasts can express IL-1β and
process it in an inflammasome-dependent manner [22–25].
In this context, it seems that IL-1β is capable of influencing
tissue repair and remodeling by inducing increased ECM
production and regulating balance between cell prolifera-
tion and apoptosis.
Numerous publications have investigated the effects of
IL-1β on vascular injury and myocardial infarction [26,
27]. It was found that the inhibition of IL-1R signaling led
to a reduction of apoptosis in heart muscle tissue upon
injury. This was achieved by overexpressing the naturally
occurring IL-1R antagonist IL-1RA or through administra-
tion of IL-1RA [26, 27]. In both cases, the authors argue
that inhibiting inflammation through IL-1RA leads to a
reduction of cardiomyocyte apoptosis, thereby allowing
accelerated recovery. Indeed, more recently, it was shown
that primary murine myoblasts do express inflammasome
components, such as NLRP3, ASC, and caspase-1, and are
able to produce IL-1β [22]. Moreover, in a genetic model
of myopathy, these inflammasome components were shown
to be up-regulated. However, despite inflammasome ex-
pression, it is still unclear whether myoblasts process pro-
IL-1β in an inflammasome-dependent manner.
The above studies suggest that inhibition of IL-1R
signaling may allow a quickened recovery from myocardial
infarction by preventing apoptosis and possibly by reducing
fibrosis and scaring. Consistent with the latter hypothesis, it
has been demonstrated that the IL-1R can mediate fibrotic
tissue reactions in a murine model of lung injury. Gasse et
al. [23] showed that bleomycin-induced lung injury leads to
the production of IL-1β, which is dependent on the
inflammasome adaptor ASC. The resulting inflammation
is caused by neutrophil infiltration, and, as a consequence
of IL-1β production, increased tissue remodeling and
fibrosis occur due to enhanced fibroblast proliferation and
collagen deposition. More recently, the same group identi-
fied monosodium urate released from dying cells as one
danger signal that can induce IL-1β in this model in an
NLRP3-dependent manner [24]. However, it is still unclear
whether the inflammatory infiltrate alone is responsible for
IL-1β production or whether resident epithelial cells are
also able to produce and process this cytokine.
It is likely that under conditions of tissue damage, IL-1β
serves a dual function as a proinflammatory cytokine that
attracts cells required for the disposal of dead cells as well
as an inducer of tissue repair. One such condition is the
inflamed joint of rheumatoid arthritis (RA) patients. IL-1β
has been implicated in RA pathology based on data from
human as well as murine models of the disease [28–30].
However, so far, it was mainly thought that IL-1β present
in the joint is mainly produced by infiltrating myeloid cells.
A study by Kolly et al. [25] characterized the expression of
inflammasome components in human rheumatoid synovium.
They identified NLRP3, ASC and caspase-1 not only in the
myeloid cells infiltrating the joint but also in endothelial cells
and synovial fibroblasts. Therefore, these cells might play an
active role in the constant repair of the joint but also the
pathology of RA.
Brain
The brain is the most sensitive organ of the body, having
extremely limited regenerative potential. In resting, normal
conditions, peripheral immune cells are unable to access the
brain and the spinal cord, the central nervous system
(CNS), due to the blood–brain barrier. The blood–brain
barrier is formed by capillary endothelia and perivascular
glial cells, and its permeability is altered by tumors or
inflammatory conditions [31], enabling immune cells such
as neutrophils or monocytes to enter the CNS under these
conditions. The infiltrating immune cells are not the only
source of inflammatory cytokines, as resident phagocytic
cells such as microglia, the resident macrophages of the
brain, or astrocytes (“macroglia”), large dendriform ecto-
dermal cells that can connect both to neurons or to cerebral
vessels, are able to synthesize a plethora of chemokines or
cytokines [32]. It has been known for several years that
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microglia can produce IL-1β to promote tissue remodeling
after CNS trauma [33], similar to the effect that IL-1β has
in connective tissue.
Overactivation of caspase-1 due to gain of function
mutations of NLRP3 can cause hereditary autoinflam-
matory diseases, such as Muckle–Wells syndrome and
neonatal-onset multisystem inflammatory disease (NOMID,
also known as chronic infantile neurological, cutaneous,
articular (CINCA)) [34]. These disorders are clinically
characterized by periodic fever accompanied by skin
rashes, amyloid depositions, and, in the case of NOMID,
severe neurological complications with hearing impairment
and respond dramatically on the treatment with IL-1R
antagonists. However, despite the obvious involvement of
IL-1β on the CNS, the precise source of IL-1β in the brain
in these rare disorders has not been identified.
Two of the most frequent neuronal diseases associated
with increased levels of IL-1β are Alzheimer's disease
(AD) and Huntington's disease (HD). In AD, amyloid β can
directly activate the NLRP3 inflammasome in microglia
cells, leading to the secretion of mature IL-1β [38]. The
amount of the proinflammatory cytokine is further in-
creased as reactive astrocytes surrounding amyloid aggre-
gates display an augmented IL-1β expression [35].
HD is an autosomal-dominant progressive neurodegen-
erative disorder associated with dementia and hyperkinetic
attacks, most probably due to an imbalance of neuronal
transmitters. Ona et al. [36] demonstrated increased
caspase-1 activation mediated by an altered Huntingtin
protein and treatment of the affected mice with the caspase-
inhibitor zVAD-fmk slowed disease progression.
In opposition to AD and HD, where IL-1 or caspase-1
appear to be required for disease progression, in a mouse
model of Parkinson's disease, mice deficient in IL-1R1, the
common receptor for both IL-1α and IL-1β, showed a
worse disease outcome compared to the control cohort [37],
implying IL-1 imparts a protective role in Parkinson's
disease.
In accordance with skin, the functional role of IL-1 in
human disease or murine disease models is better charac-
terized than the actual tissue expression of NLRs. Murine
microglia are known to harbor caspase-1, pro-IL-1β,
NLRP3, and caspase-1, similar to macrophages outside
the CNS [38]. de Rivero Vaccari et al. [39] demonstrated
the presence of caspase-1, caspase-11, ASC, and NLRP1 in
motor neurons in the ventral horn of spinal cords, with
increased expression upon spinal cord injury. While spinal
cord injury induces processing of IL-1β and IL-18, with an
accumulation of intracellular cleaved IL-1β and IL-18,
whether these mature cytokines are efficiently secreted has
not been demonstrated.
Yin et al. [40] determined the expression of NLRs, IL-
1β, and caspase-1 at the RNA level using various tissue
cDNA libraries, including the brain, and concluded from
their expression levels that the brain could be classified as
“ready to go” for NLRP1 and NLRP3 inflammasome
activation. However, due to the utilization of a tissue
cDNA library, the exact cell type expressing the above
inflammasome components remains unclear. Moreover, it
cannot be excluded that contaminating blood cells or the
lack of a priming signal might bias the above analysis.
Conclusions
Historically, it has been assumed that the only sources of
IL-1β are cells of myeloid origin infiltrating the site of
inflammation. However, it is now becoming clear that in
several tissues, nonmyeloid cells are able to produce and
process IL-1β. It is, therefore, reasonable to assume that the
production of IL-1β by tissue resident cells serves as an
early response to infections in immune deprived tissues,
such as the brain, joint, or the epidermis of the skin, thereby
attracting immune cells. Moreover, besides its role as a
potent proinflammatory cytokine, increasing evidence
suggests that IL-1β may also function in tissue remodeling
and repair.
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